NeuroMetrix, Inc. (NURO)
NASDAQ: NURO · IEX Real-Time Price · USD
4.440
+0.070 (1.60%)
At close: May 1, 2024, 4:00 PM
4.700
+0.260 (5.86%)
After-hours: May 1, 2024, 5:00 PM EDT

NeuroMetrix Revenue

In the year 2023, NeuroMetrix had annual revenue of $5.90M, a decrease of -28.52%. Revenue in the quarter ending December 31, 2023 was $1.32M, a -28.67% decrease year-over-year.

Revenue (ttm)
$5.90M
Revenue Growth
-28.52%
P/S Ratio
1.49
Revenue / Employee
$226,978
Employees
26
Market Cap
8.82M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.90M-2.35M-28.52%
Dec 31, 20228.26M2.58K0.03%
Dec 31, 20218.25M875.52K11.87%
Dec 31, 20207.38M-1.89M-20.43%
Dec 31, 20199.27M-6.82M-42.37%
Dec 31, 201816.09M-1.00M-5.86%
Dec 31, 201717.09M5.06M42.11%
Dec 31, 201612.03M4.73M64.76%
Dec 31, 20157.30M1.79M32.42%
Dec 31, 20145.51M233.96K4.43%
Dec 31, 20135.28M-2.30M-30.32%
Dec 31, 20127.58M-2.82M-27.14%
Dec 31, 201110.40M-3.50M-25.20%
Dec 31, 201013.90M-12.24M-46.82%
Dec 31, 200926.14M-4.98M-16.01%
Dec 31, 200831.12M-12.55M-28.73%
Dec 31, 200743.67M-11.58M-20.96%
Dec 31, 200655.25M20.95M61.09%
Dec 31, 200534.30M16.38M91.39%
Dec 31, 200417.92M8.75M95.47%
Dec 31, 20039.17M4.94M116.98%
Dec 31, 20024.23M760.63K21.96%
Dec 31, 20013.46M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Molecular Templates 57.31M
TRxADE HEALTH 8.27M
Aeterna Zentaris 4.50M
Notable Labs 310.00K
Kazia Therapeutics 15.65K
Revenue Rankings